Efficacy and tolerability of vemurafenib in patients with BRAFV600E positive papillary thyroid cancer: M.D. Anderson Cancer center off label experience

Research output: Contribution to journalArticlepeer-review

106 Scopus citations

Fingerprint

Dive into the research topics of 'Efficacy and tolerability of vemurafenib in patients with BRAFV600E positive papillary thyroid cancer: M.D. Anderson Cancer center off label experience'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemistry